Global Dermatomycoses Drug Market Research Report 2018 Opportunities, Size, Cost Structure, Service Provider, Segmentation, Shares, Forecast to 2023

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

 Published Date : Feb-2018   |    Format :PDF   |    Number of Pages : 113
This report studies Dermatomycoses Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Anacor Pharmaceuticals Inc
    Biolab Farmaceutica Ltda
    Blueberry Therapeutics Ltd
    Daewoong Pharmaceutical Co Ltd
    Dermala Inc
    Helix BioMedix Inc
    Novan Inc
    Sol-Gel Technologies Ltd
    TGV-Laboratories
    Viamet Pharmaceuticals Inc
    Vyome Biosciences Pvt Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    BB-2603
    Clotrimazole
    Dapaconazole
    Others

By Application, the market can be split into
    Hospital
    Clinic
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Dermatomycoses Drug Market Professional Survey Report 2018
1 Industry Overview of Dermatomycoses Drug
    1.1 Definition and Specifications of Dermatomycoses Drug
        1.1.1 Definition of Dermatomycoses Drug
        1.1.2 Specifications of Dermatomycoses Drug
    1.2 Classification of Dermatomycoses Drug
        1.2.1 BB-2603
        1.2.2 Clotrimazole
        1.2.3 Dapaconazole
        1.2.4 Others
    1.3 Applications of Dermatomycoses Drug
        1.3.1 Hospital
        1.3.2 Clinic
        1.3.3 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Dermatomycoses Drug
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Dermatomycoses Drug
    2.3 Manufacturing Process Analysis of Dermatomycoses Drug
    2.4 Industry Chain Structure of Dermatomycoses Drug

3 Technical Data and Manufacturing Plants Analysis of Dermatomycoses Drug
    3.1 Capacity and Commercial Production Date of Global Dermatomycoses Drug Major Manufacturers in 2017
    3.2 Manufacturing Plants Distribution of Global Dermatomycoses Drug Major Manufacturers in 2017
    3.3 R&D Status and Technology Source of Global Dermatomycoses Drug Major Manufacturers in 2017
    3.4 Raw Materials Sources Analysis of Global Dermatomycoses Drug Major Manufacturers in 2017

4 Global Dermatomycoses Drug Overall Market Overview
    4.1 2013-2018E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2013-2018E Global Dermatomycoses Drug Capacity and Growth Rate Analysis
        4.2.2 2017 Dermatomycoses Drug Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2013-2018E Global Dermatomycoses Drug Sales and Growth Rate Analysis
        4.3.2 2017 Dermatomycoses Drug Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2013-2018E Global Dermatomycoses Drug Sales Price
        4.4.2 2017 Dermatomycoses Drug Sales Price Analysis (Company Segment)

5 Dermatomycoses Drug Regional Market Analysis
    5.1 North America Dermatomycoses Drug Market Analysis
        5.1.1 North America Dermatomycoses Drug Market Overview
        5.1.2 North America 2013-2018E Dermatomycoses Drug Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2013-2018E Dermatomycoses Drug Sales Price Analysis
        5.1.4 North America 2017 Dermatomycoses Drug Market Share Analysis
    5.2 China Dermatomycoses Drug Market Analysis
        5.2.1 China Dermatomycoses Drug Market Overview
        5.2.2 China 2013-2018E Dermatomycoses Drug Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2013-2018E Dermatomycoses Drug Sales Price Analysis
        5.2.4 China 2017 Dermatomycoses Drug Market Share Analysis
    5.3 Europe Dermatomycoses Drug Market Analysis
        5.3.1 Europe Dermatomycoses Drug Market Overview
        5.3.2 Europe 2013-2018E Dermatomycoses Drug Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2013-2018E Dermatomycoses Drug Sales Price Analysis
        5.3.4 Europe 2017 Dermatomycoses Drug Market Share Analysis
    5.4 Southeast Asia Dermatomycoses Drug Market Analysis
        5.4.1 Southeast Asia Dermatomycoses Drug Market Overview
        5.4.2 Southeast Asia 2013-2018E Dermatomycoses Drug Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2013-2018E Dermatomycoses Drug Sales Price Analysis
        5.4.4 Southeast Asia 2017 Dermatomycoses Drug Market Share Analysis
    5.5 Japan Dermatomycoses Drug Market Analysis
        5.5.1 Japan Dermatomycoses Drug Market Overview
        5.5.2 Japan 2013-2018E Dermatomycoses Drug Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2013-2018E Dermatomycoses Drug Sales Price Analysis
        5.5.4 Japan 2017 Dermatomycoses Drug Market Share Analysis
    5.6 India Dermatomycoses Drug Market Analysis
        5.6.1 India Dermatomycoses Drug Market Overview
        5.6.2 India 2013-2018E Dermatomycoses Drug Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2013-2018E Dermatomycoses Drug Sales Price Analysis
        5.6.4 India 2017 Dermatomycoses Drug Market Share Analysis

6 Global 2013-2018E Dermatomycoses Drug Segment Market Analysis (by Type)
    6.1 Global 2013-2018E Dermatomycoses Drug Sales by Type
    6.2 Different Types of Dermatomycoses Drug Product Interview Price Analysis
    6.3 Different Types of Dermatomycoses Drug Product Driving Factors Analysis
        6.3.1 BB-2603 of Dermatomycoses Drug Growth Driving Factor Analysis
        6.3.2 Clotrimazole of Dermatomycoses Drug Growth Driving Factor Analysis
        6.3.3 Dapaconazole of Dermatomycoses Drug Growth Driving Factor Analysis
        6.3.4 Others of Dermatomycoses Drug Growth Driving Factor Analysis

7 Global 2013-2018E Dermatomycoses Drug Segment Market Analysis (by Application)
    7.1 Global 2013-2018E Dermatomycoses Drug Consumption by Application
    7.2 Different Application of Dermatomycoses Drug Product Interview Price Analysis
    7.3 Different Application of Dermatomycoses Drug Product Driving Factors Analysis
        7.3.1 Hospital of Dermatomycoses Drug Growth Driving Factor Analysis
        7.3.2 Clinic of Dermatomycoses Drug Growth Driving Factor Analysis
        7.3.3 Others of Dermatomycoses Drug Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Dermatomycoses Drug
    8.1 Anacor Pharmaceuticals Inc
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Anacor Pharmaceuticals Inc 2017 Dermatomycoses Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Anacor Pharmaceuticals Inc 2017 Dermatomycoses Drug Business Region Distribution Analysis
    8.2 Biolab Farmaceutica Ltda
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Biolab Farmaceutica Ltda 2017 Dermatomycoses Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Biolab Farmaceutica Ltda 2017 Dermatomycoses Drug Business Region Distribution Analysis
    8.3 Blueberry Therapeutics Ltd
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Blueberry Therapeutics Ltd 2017 Dermatomycoses Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Blueberry Therapeutics Ltd 2017 Dermatomycoses Drug Business Region Distribution Analysis
    8.4 Daewoong Pharmaceutical Co Ltd
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Daewoong Pharmaceutical Co Ltd 2017 Dermatomycoses Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Daewoong Pharmaceutical Co Ltd 2017 Dermatomycoses Drug Business Region Distribution Analysis
    8.5 Dermala Inc
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Dermala Inc 2017 Dermatomycoses Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Dermala Inc 2017 Dermatomycoses Drug Business Region Distribution Analysis
    8.6 Helix BioMedix Inc
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Helix BioMedix Inc 2017 Dermatomycoses Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Helix BioMedix Inc 2017 Dermatomycoses Drug Business Region Distribution Analysis
    8.7 Novan Inc
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Novan Inc 2017 Dermatomycoses Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Novan Inc 2017 Dermatomycoses Drug Business Region Distribution Analysis
    8.8 Sol-Gel Technologies Ltd
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Sol-Gel Technologies Ltd 2017 Dermatomycoses Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Sol-Gel Technologies Ltd 2017 Dermatomycoses Drug Business Region Distribution Analysis
    8.9 TGV-Laboratories
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 TGV-Laboratories 2017 Dermatomycoses Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 TGV-Laboratories 2017 Dermatomycoses Drug Business Region Distribution Analysis
    8.10 Viamet Pharmaceuticals Inc
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Viamet Pharmaceuticals Inc 2017 Dermatomycoses Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Viamet Pharmaceuticals Inc 2017 Dermatomycoses Drug Business Region Distribution Analysis
    8.11 Vyome Biosciences Pvt Ltd

9 Development Trend of Analysis of Dermatomycoses Drug Market
    9.1 Global Dermatomycoses Drug Market Trend Analysis
        9.1.1 Global 2018-2025 Dermatomycoses Drug Market Size (Volume and Value) Forecast
        9.1.2 Global 2018-2025 Dermatomycoses Drug Sales Price Forecast
    9.2 Dermatomycoses Drug Regional Market Trend
        9.2.1 North America 2018-2025 Dermatomycoses Drug Consumption Forecast
        9.2.2 China 2018-2025 Dermatomycoses Drug Consumption Forecast
        9.2.3 Europe 2018-2025 Dermatomycoses Drug Consumption Forecast
        9.2.4 Southeast Asia 2018-2025 Dermatomycoses Drug Consumption Forecast
        9.2.5 Japan 2018-2025 Dermatomycoses Drug Consumption Forecast
        9.2.6 India 2018-2025 Dermatomycoses Drug Consumption Forecast
    9.3 Dermatomycoses Drug Market Trend (Product Type)
    9.4 Dermatomycoses Drug Market Trend (Application)

10 Dermatomycoses Drug Marketing Type Analysis
    10.1 Dermatomycoses Drug Regional Marketing Type Analysis
    10.2 Dermatomycoses Drug International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Dermatomycoses Drug by Region
    10.4 Dermatomycoses Drug Supply Chain Analysis

11 Consumers Analysis of Dermatomycoses Drug
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Dermatomycoses Drug Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source


List of Tables and Figures
    Figure Picture of Dermatomycoses Drug
    Table Product Specifications of Dermatomycoses Drug
    Table Classification of Dermatomycoses Drug
    Figure Global Production Market Share of Dermatomycoses Drug by Type in 2017
    Figure BB-2603 Picture
    Table Major Manufacturers of BB-2603
    Figure Clotrimazole Picture
    Table Major Manufacturers of Clotrimazole
    Figure Dapaconazole Picture
    Table Major Manufacturers of Dapaconazole
    Figure Others Picture
    Table Major Manufacturers of Others
    Table Applications of Dermatomycoses Drug
    Figure Global Consumption Volume Market Share of Dermatomycoses Drug by Application in 2017
    Figure Hospital Examples
    Table Major Consumers in Hospital
    Figure Clinic Examples
    Table Major Consumers in Clinic
    Figure Others Examples
    Table Major Consumers in Others
    Figure Market Share of Dermatomycoses Drug by Regions
    Figure North America Dermatomycoses Drug Market Size (Million USD) (2013-2025)
    Figure China Dermatomycoses Drug Market Size (Million USD) (2013-2025)
    Figure Europe Dermatomycoses Drug Market Size (Million USD) (2013-2025)
    Figure Southeast Asia Dermatomycoses Drug Market Size (Million USD) (2013-2025)
    Figure Japan Dermatomycoses Drug Market Size (Million USD) (2013-2025)
    Figure India Dermatomycoses Drug Market Size (Million USD) (2013-2025)
    Table Dermatomycoses Drug Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Dermatomycoses Drug in 2017
    Figure Manufacturing Process Analysis of Dermatomycoses Drug
    Figure Industry Chain Structure of Dermatomycoses Drug
    Table Capacity and Commercial Production Date of Global Dermatomycoses Drug Major Manufacturers in 2017
    Table Manufacturing Plants Distribution of Global Dermatomycoses Drug Major Manufacturers in 2017
    Table R&D Status and Technology Source of Global Dermatomycoses Drug Major Manufacturers in 2017
    Table Raw Materials Sources Analysis of Global Dermatomycoses Drug Major Manufacturers in 2017
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Dermatomycoses Drug 2013-2018E
    Figure Global 2013-2018E Dermatomycoses Drug Market Size (Volume) and Growth Rate
    Figure Global 2013-2018E Dermatomycoses Drug Market Size (Value) and Growth Rate
    Table 2013-2018E Global Dermatomycoses Drug Capacity and Growth Rate
    Table 2017 Global Dermatomycoses Drug Capacity (K Units) List (Company Segment)
    Table 2013-2018E Global Dermatomycoses Drug Sales (K Units) and Growth Rate
    Table 2017 Global Dermatomycoses Drug Sales (K Units) List (Company Segment)
    Table 2013-2018E Global Dermatomycoses Drug Sales Price (USD/Unit)
    Table 2017 Global Dermatomycoses Drug Sales Price (USD/Unit) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K Units) of Dermatomycoses Drug 2013-2018E 
    Figure North America 2013-2018E Dermatomycoses Drug Sales Price (USD/Unit)
    Figure North America 2017 Dermatomycoses Drug Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K Units) of Dermatomycoses Drug 2013-2018E 
    Figure China 2013-2018E Dermatomycoses Drug Sales Price (USD/Unit) 
    Figure China 2017 Dermatomycoses Drug Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K Units) of Dermatomycoses Drug 2013-2018E
    Figure Europe 2013-2018E Dermatomycoses Drug Sales Price (USD/Unit)
    Figure Europe 2017 Dermatomycoses Drug Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Dermatomycoses Drug 2013-2018E
    Figure Southeast Asia 2013-2018E Dermatomycoses Drug Sales Price (USD/Unit)
    Figure Southeast Asia 2017 Dermatomycoses Drug Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K Units) of Dermatomycoses Drug 2013-2018E
    Figure Japan 2013-2018E Dermatomycoses Drug Sales Price (USD/Unit)
    Figure Japan 2017 Dermatomycoses Drug Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K Units) of Dermatomycoses Drug 2013-2018E
    Figure India 2013-2018E Dermatomycoses Drug Sales Price (USD/Unit)
    Figure India 2017 Dermatomycoses Drug Sales Market Share
    Table Global 2013-2018E Dermatomycoses Drug Sales (K Units) by Type
    Table Different Types Dermatomycoses Drug Product Interview Price
    Table Global 2013-2018E Dermatomycoses Drug Sales (K Units) by Application
    Table Different Application Dermatomycoses Drug Product Interview Price
    Table Anacor Pharmaceuticals Inc Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Anacor Pharmaceuticals Inc Dermatomycoses Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Anacor Pharmaceuticals Inc Dermatomycoses Drug Business Region Distribution
    Table Biolab Farmaceutica Ltda Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Biolab Farmaceutica Ltda Dermatomycoses Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Biolab Farmaceutica Ltda Dermatomycoses Drug Business Region Distribution
    Table Blueberry Therapeutics Ltd Information List
    Table Product A Overview
    Table Product B Overview
    Table 2015 Blueberry Therapeutics Ltd Dermatomycoses Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Blueberry Therapeutics Ltd Dermatomycoses Drug Business Region Distribution
    Table Daewoong Pharmaceutical Co Ltd Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Business Region Distribution
    Table Dermala Inc Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Dermala Inc Dermatomycoses Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Dermala Inc Dermatomycoses Drug Business Region Distribution
    Table Helix BioMedix Inc Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Helix BioMedix Inc Dermatomycoses Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Helix BioMedix Inc Dermatomycoses Drug Business Region Distribution
    Table Novan Inc Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Novan Inc Dermatomycoses Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Novan Inc Dermatomycoses Drug Business Region Distribution
    Table Sol-Gel Technologies Ltd Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Sol-Gel Technologies Ltd Dermatomycoses Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Sol-Gel Technologies Ltd Dermatomycoses Drug Business Region Distribution
    Table TGV-Laboratories Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 TGV-Laboratories Dermatomycoses Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 TGV-Laboratories Dermatomycoses Drug Business Region Distribution
    Table Viamet Pharmaceuticals Inc Information List
    Table Product A Overview
    Table Product B Overview
    Table 2017 Viamet Pharmaceuticals Inc Dermatomycoses Drug Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
    Figure 2017 Viamet Pharmaceuticals Inc Dermatomycoses Drug Business Region Distribution
    Table Vyome Biosciences Pvt Ltd Information List
    Figure Global 2018-2025 Dermatomycoses Drug Market Size (K Units) and Growth Rate Forecast
    Figure Global 2018-2025 Dermatomycoses Drug Market Size (Million USD) and Growth Rate Forecast
    Figure Global 2018-2025 Dermatomycoses Drug Sales Price (USD/Unit) Forecast
    Figure North America 2018-2025 Dermatomycoses Drug Consumption Volume (K Units) and Growth Rate Forecast
    Figure China 2018-2025 Dermatomycoses Drug Consumption Volume (K Units) and Growth Rate Forecast
    Figure Europe 2018-2025 Dermatomycoses Drug Consumption Volume (K Units) and Growth Rate Forecast
    Figure Southeast Asia 2018-2025 Dermatomycoses Drug Consumption Volume (K Units) and Growth Rate Forecast
    Figure Japan 2018-2025 Dermatomycoses Drug Consumption Volume (K Units) and Growth Rate Forecast
    Figure India 2018-2025 Dermatomycoses Drug Consumption Volume (K Units) and Growth Rate Forecast
    Table Global Sales Volume (K Units) of Dermatomycoses Drug by Type 2018-2025
    Table Global Consumption Volume (K Units) of Dermatomycoses Drug by Application 2018-2025
    Table Traders or Distributors with Contact Information of Dermatomycoses Drug by Region



Latest News

03-Dec-2018 | Technology

Don’t await a 5G iPhone on or before 2020

Apple’s timeline for adopting the next generation of cellular connectivity, 5G, by suggesting the first compatible iPhone won’t come before 2020. Earlier rumors and reports pointed to t ...

31-Oct-2018 | Medical Care

Obesity, low BMI linked to increased risk of death, study reveals

The study, published Wednesday in The Lancet Diabetes and Endocrinology and conducted by scientists at London School of Hygiene and Tropical Medicine, revealed that BMI that's either too high o ...

11-Aug-2018 | Electrical & Electronic Device

Samsung leads the pack, Smartphone Market in India Grows 29% In Third Quarter

The shipments of mobile in India are expected to reach the mark of 262 Million units till the fourth quarter arrives. Relying on the numbers, vendors dealing in mobile shipped approximately 80 Mill ...

18-Jul-2018 | Chemicals & Materials

It is Possible!! Can News Reports Be Automated?

Artificial intelligence is currently the hot topic of the town owing to its efficiency and quick work. It is a technology that is currently being used for a number of applications in the various se ...

26-Jun-2018 | Electrical & Electronic Device

Vodafone to Make Stronger Enterprise Portfolio Thus Bolstering Global Telecom Market

Vodafone India is seeking at the broadband segment to fortify its venture portfolio, said the Sunil Sood, the MD and CEO of the telecom company. The carriers had posted 2x development in the enterp ...